• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在免疫相关不良事件检测中的作用。

Role for Artificial Intelligence in the Detection of Immune-Related Adverse Events.

作者信息

Elsaid Mohamed I, Meara Alexa Simon, Owen Dwight H

机构信息

Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH.

Division of Medical Oncology, College of Medicine, The Ohio State University, Columbus, OH.

出版信息

J Clin Oncol. 2024 Dec 10;42(35):4119-4122. doi: 10.1200/JCO-24-01570. Epub 2024 Oct 2.

DOI:10.1200/JCO-24-01570
PMID:39356977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12172021/
Abstract

In the article that accompanies this editorial, Sun and colleagues utilized large language models (LLMs) to detect immune-related adverse events (irAEs) from electronic health records and demonstrated that LLMs had higher sensitivity than ICD codes alone (94.7% vs 68.7% respectively) and similar specificity, requiring a fraction of the time compared to manual adjudication. This research represents a significant step in enhancing the efficiency of our efforts to better understand irAEs by leveraging data in the electronic medical records from patients treated with immune checkpoint inhibitors over the last 15 years to better predict these toxicities, with the goal of minimizing or mitigating them entirely.

摘要

在这篇社论所附的文章中,孙及其同事利用大语言模型(LLMs)从电子健康记录中检测免疫相关不良事件(irAEs),并证明大语言模型比单独使用国际疾病分类(ICD)编码具有更高的敏感性(分别为94.7%和68.7%)以及相似的特异性,与人工判定相比所需时间仅为一小部分。这项研究代表了一个重要的进展,即通过利用过去15年接受免疫检查点抑制剂治疗患者的电子病历数据,提高我们更好地理解irAEs的效率,从而更好地预测这些毒性反应,目标是将其降至最低或完全缓解。

相似文献

1
Role for Artificial Intelligence in the Detection of Immune-Related Adverse Events.人工智能在免疫相关不良事件检测中的作用。
J Clin Oncol. 2024 Dec 10;42(35):4119-4122. doi: 10.1200/JCO-24-01570. Epub 2024 Oct 2.
2
Polyp detection with colonoscopy assisted by the GI Genius artificial intelligence endoscopy module compared with standard colonoscopy in routine colonoscopy practice (COLO-DETECT): a multicentre, open-label, parallel-arm, pragmatic randomised controlled trial.基于 GI Genius 人工智能内镜模块的结肠镜辅助下息肉检测与常规结肠镜检查比较(COLO-DETECT):一项多中心、开放标签、平行臂、实用随机对照试验。
Lancet Gastroenterol Hepatol. 2024 Oct;9(10):911-923. doi: 10.1016/S2468-1253(24)00161-4. Epub 2024 Aug 14.
3
Artificial intelligence methods applied to longitudinal data from electronic health records for prediction of cancer: a scoping review.应用于电子健康记录纵向数据以预测癌症的人工智能方法:一项范围综述。
BMC Med Res Methodol. 2025 Jan 28;25(1):24. doi: 10.1186/s12874-025-02473-w.
4
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial.人工智能辅助系统与白光内镜单独用于林奇综合征患者腺瘤检测的比较(TIMELY):一项国际、多中心、随机对照试验。
Lancet Gastroenterol Hepatol. 2024 Sep;9(9):802-810. doi: 10.1016/S2468-1253(24)00187-0. Epub 2024 Jul 19.
5
A systematic review and meta-analysis of artificial intelligence software for tuberculosis diagnosis using chest X-ray imaging.一项关于使用胸部X光成像的人工智能软件进行结核病诊断的系统评价和荟萃分析。
J Thorac Dis. 2025 May 30;17(5):3223-3237. doi: 10.21037/jtd-2025-604. Epub 2025 May 27.
6
Integrating artificial intelligence in healthcare practice: challenges and future prospects.将人工智能整合到医疗实践中:挑战与未来前景。
Wiad Lek. 2025;78(5):1199-1205. doi: 10.36740/WLek/205397.
7
Evaluation of an artificial intelligence-based decision support for the detection of cutaneous melanoma in primary care: a prospective real-life clinical trial.基于人工智能的决策支持在初级保健中用于检测皮肤黑色素瘤的评估:一项前瞻性真实世界临床试验。
Br J Dermatol. 2024 Jun 20;191(1):125-133. doi: 10.1093/bjd/ljae021.
8
Artificial Intelligence-Powered Training Database for Clinical Thinking: App Development Study.用于临床思维的人工智能训练数据库:应用程序开发研究
JMIR Form Res. 2025 Jan 3;9:e58426. doi: 10.2196/58426.
9
Prediction of Anti-rheumatoid Arthritis Natural Products of Xanthocerais Lignum Based on LC-MS and Artificial Intelligence.基于液相色谱-质谱联用技术和人工智能的抗类风湿性关节炎天然产物黄羊角木预测
Comb Chem High Throughput Screen. 2025;28(4):627-646. doi: 10.2174/0113862073282138240116112348.
10
Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer.用于生物相关人工智能的多模态数据整合,以指导II期结直肠癌的辅助化疗。
EBioMedicine. 2025 Jun 4;117:105789. doi: 10.1016/j.ebiom.2025.105789.

本文引用的文献

1
Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis.临床试验中免疫检查点抑制剂的治疗相关不良事件:一项系统评价和荟萃分析。
Front Oncol. 2024 May 17;14:1391724. doi: 10.3389/fonc.2024.1391724. eCollection 2024.
2
Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights.风湿免疫相关不良事件:当前临床要务支撑未来新见解
Rheum Dis Clin North Am. 2024 May;50(2):xvii-xix. doi: 10.1016/j.rdc.2024.02.008. Epub 2024 Feb 23.
3
Immune-Related Adverse Events of Immune Checkpoint Inhibitors.免疫检查点抑制剂的免疫相关不良反应。
Ann Intern Med. 2024 Feb;177(2):ITC17-ITC32. doi: 10.7326/AITC202402200. Epub 2024 Feb 13.
4
Generalizability of machine learning methods in detecting adverse drug events from clinical narratives in electronic medical records.机器学习方法在从电子病历中的临床叙述中检测药物不良事件方面的可推广性。
Front Pharmacol. 2023 Jul 12;14:1218679. doi: 10.3389/fphar.2023.1218679. eCollection 2023.
5
Immune-related adverse events of immune checkpoint inhibitors: a review.免疫检查点抑制剂的免疫相关不良反应:综述。
Front Immunol. 2023 May 25;14:1167975. doi: 10.3389/fimmu.2023.1167975. eCollection 2023.
6
Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research.免疫检查点抑制剂并发症的ICD编码缺失阻碍了临床护理和研究。
J Endocr Soc. 2023 Feb 1;7(4):bvad019. doi: 10.1210/jendso/bvad019. eCollection 2023 Feb 9.
7
Adverse Event Reporting Quality in Cancer Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy: A Systematic Review.免疫检查点抑制剂治疗的癌症临床试验中不良事件报告质量的系统评价。
Front Immunol. 2022 Jul 7;13:874829. doi: 10.3389/fimmu.2022.874829. eCollection 2022.
8
The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.免疫相关不良事件在 PD-1/PD-L1 抑制剂中的报告不一致且不充分:一项随机对照临床试验的系统评价。
Oncologist. 2021 Dec;26(12):e2239-e2246. doi: 10.1002/onco.13940. Epub 2021 Aug 31.
9
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data.免疫检查点抑制剂相关的免疫相关不良事件:呼吁收集和共享临床试验和真实世界数据。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002896.
10
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.免疫检查点抑制剂治疗患者皮肤毒性的发生的流行病学和危险因素:美国人群水平分析。
J Am Acad Dermatol. 2022 Mar;86(3):563-572. doi: 10.1016/j.jaad.2021.03.094. Epub 2021 Apr 2.